Shanghai OPM Biosciences Revenue

In the year 2025, Shanghai OPM Biosciences had annual revenue of 354.91M CNY with 19.40% growth. Shanghai OPM Biosciences had revenue of 83.39M in the quarter ending December 31, 2025, with 2.46% growth.

Revenue

354.91M

Revenue Growth

+19.40%

P/S Ratio

20.31

Revenue / Employee

1.08M

Employees

Market Cap

7.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	354.91M	57.67M	19.40%
Dec 31, 2024	297.24M	54.12M	22.26%
Dec 31, 2023	243.12M	-51.24M	-17.41%
Dec 31, 2022	294.37M	81.68M	38.41%
Dec 31, 2021	212.68M	87.71M	70.19%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Suzhou Fengbei Biotech Stock	3.17B
Jiangsu Aidea Pharmaceutical Group	719.17M
Anhui Huaheng Biotechnology	2.95B
Chengdu Kanghua Biological Products	1.17B
Acrobiosystems	838.12M
Wuhan Keqian Biology Co.,Ltd	949.74M
Nanjing Vazyme Biotech	1.41B
Daan Gene	737.96M

Revenue Rankings